Skip to Content

Estropipate

In the US, Estropipate (estropipate systemic) is a member of the drug class estrogens and is used to treat Atrophic Urethritis, Atrophic Vaginitis, Hypoestrogenism, Oophorectomy, Osteoporosis, Postmenopausal Symptoms and Primary Ovarian Failure.

US matches:

Scheme

BAN

CAS registry number (Chemical Abstracts Service)

0007280-37-7

Chemical Formula

C22-H32-N2-O5-S

Molecular Weight

436

Therapeutic Category

Estrogen

Chemical Name

Estra-1,3,5(10)-trien-17-one, 3-(sulfooxy)-, compd. wit piperazine (1:1)

Foreign Name

  • Estron 3-hydrogensulfat, Piperazinsalz (German)

Generic Names

  • Estropipate (OS: BAN)
  • Estropin (IS)
  • Piperazine Estrone Sulfate (IS)
  • Piperazine oestrone sulfate (IS)
  • Estropipate (PH: BP 2016, USP 38)

Brand Names

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide